Percutaneous coronary intervention or coronary artery bypass graft surgery for left main coronary artery disease: A meta-analysis of randomized trials.
Publication
, Journal Article
Kuno, T; Ueyama, H; Rao, SV; Cohen, MG; Tamis-Holland, JE; Thompson, C; Takagi, H; Bangalore, S
Published in: Am Heart J
September 2020
We aimed to investigate long-term (≥5 years) outcomes of percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) for left main coronary artery disease (LMCAD) using a meta-analysis from updated published randomized trials. Our data showed that the risk of all-cause death as well as cardiovascular death, myocardial infarction, and stroke was similar between PCI and CABG, whereas PCI had significantly higher rates of repeat revascularization compared to CABG. Decisions for PCI versus CABG for LMCAD should be based on weighing the upfront morbidity and mortality risk of CABG with late risk of repeat revascularization with PCI and taking into consideration patient preference.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
September 2020
Volume
227
Start / End Page
9 / 10
Location
United States
Related Subject Headings
- Treatment Outcome
- Time Factors
- Randomized Controlled Trials as Topic
- Percutaneous Coronary Intervention
- Humans
- Coronary Artery Disease
- Coronary Artery Bypass
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
Citation
APA
Chicago
ICMJE
MLA
NLM
Kuno, T., Ueyama, H., Rao, S. V., Cohen, M. G., Tamis-Holland, J. E., Thompson, C., … Bangalore, S. (2020). Percutaneous coronary intervention or coronary artery bypass graft surgery for left main coronary artery disease: A meta-analysis of randomized trials. Am Heart J, 227, 9–10. https://doi.org/10.1016/j.ahj.2020.06.001
Kuno, Toshiki, Hiroki Ueyama, Sunil V. Rao, Mauricio G. Cohen, Jacqueline E. Tamis-Holland, Craig Thompson, Hisato Takagi, and Sripal Bangalore. “Percutaneous coronary intervention or coronary artery bypass graft surgery for left main coronary artery disease: A meta-analysis of randomized trials.” Am Heart J 227 (September 2020): 9–10. https://doi.org/10.1016/j.ahj.2020.06.001.
Kuno T, Ueyama H, Rao SV, Cohen MG, Tamis-Holland JE, Thompson C, et al. Percutaneous coronary intervention or coronary artery bypass graft surgery for left main coronary artery disease: A meta-analysis of randomized trials. Am Heart J. 2020 Sep;227:9–10.
Kuno, Toshiki, et al. “Percutaneous coronary intervention or coronary artery bypass graft surgery for left main coronary artery disease: A meta-analysis of randomized trials.” Am Heart J, vol. 227, Sept. 2020, pp. 9–10. Pubmed, doi:10.1016/j.ahj.2020.06.001.
Kuno T, Ueyama H, Rao SV, Cohen MG, Tamis-Holland JE, Thompson C, Takagi H, Bangalore S. Percutaneous coronary intervention or coronary artery bypass graft surgery for left main coronary artery disease: A meta-analysis of randomized trials. Am Heart J. 2020 Sep;227:9–10.
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
September 2020
Volume
227
Start / End Page
9 / 10
Location
United States
Related Subject Headings
- Treatment Outcome
- Time Factors
- Randomized Controlled Trials as Topic
- Percutaneous Coronary Intervention
- Humans
- Coronary Artery Disease
- Coronary Artery Bypass
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services